9th Circ. Undoes $278M Eli Lilly Payment In Insulin Case
By Elliot Weld · February 25, 2026, 6:46 PM EST
The Ninth Circuit ruled against a lower court Wednesday in saying pharmaceutical giant Eli Lilly does not owe $278 million in royalties to an Arizona company for insulin-brands sales, saying an...
To view the full article, register now.